Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18.3Revenue $M4.1Net Margin (%)-267.6Z-Score-19.8
Enterprise Value $M13.9EPS $-0.6Operating Margin %-240.6F-Score4
P/E(ttm))0Cash Flow Per Share $-0.9Pre-tax Margin (%)-267.6Higher ROA y-yY
Price/Book5.110-y EBITDA Growth Rate %0Quick Ratio1.6Cash flow > EarningsN
Price/Sales4.75-y EBITDA Growth Rate %-45.1Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-88.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-249.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M34.4ROI % (ttm)-134.3Gross Margin Increase y-yY

Gurus Latest Trades with BGMD

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BGMD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

BGMD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
AFEYAN NOUBARDirector, 10% Owner 2013-01-30Buy2,000,000$2-70 view
PAPADOPOULOS STELIOSDirector 2013-01-30Buy250,000$2-70 view
Posner Brian SDirector 2012-11-19Buy10,000$1.17-48.72 view
Bancel StephaneExecutive Chairman 2012-11-15Buy100,000$1.26-52.38 view
AFEYAN NOUBARDirector, 10% Owner 2012-08-20Sell82$5.83-89.71 view
Muntendam PieterEVP, Chief Medical Officer 2012-06-08Sell33,986$5.48-89.05 view
Bouvier EricPresident, CEO 2012-05-23Buy10,000$3.95-84.81 view
Posner Brian SDirector 2012-05-22Buy10,000$4.04-85.15 view
AFEYAN NOUBARDirector, 10% Owner 2012-05-21Sell141$3.95-84.81 view
Bancel StephaneExecutive Chairman 2012-05-17Buy5,008$3.84-84.38 view

Press Releases about BGMD :

    Quarterly/Annual Reports about BGMD:

    News about BGMD:

    Articles On GuruFocus.com
    comment on BGMD Jun 09 2011 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Sep 16 2014
    Most active Nasdaq-traded stocks Sep 16 2014
    BG MEDICINE, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Notice of... Sep 11 2014
    BG MEDICINE, INC. Financials Aug 22 2014
    BG MEDICINE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 14 2014
    BG Medicine Reports Second Quarter 2014 Financial Results Aug 14 2014
    Q2 2014 BG Medicine Inc Earnings Release - Before Market Open Aug 14 2014
    BG Medicine Announces Q2 2014 Financial Results Release Date and Conference Call Information Aug 07 2014
    BG MEDICINE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 05 2014
    5 Stocks Under $10 Set to Soar May 29 2014
    Covance Expands in Market Access May 20 2014
    Why BG Medicine (BGMD) Stock Is Plunging Today May 14 2014
    BG Medicine's (BGMD) CEO, Paul Sohmer on Q1 2014 Results - Earnings Call Transcript May 14 2014
    BG MEDICINE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... May 14 2014
    BG Medicine reports Q1 EPS (8c), one estimate (8c) May 14 2014
    BG MEDICINE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Apr 03 2014
    Why BG Medicine (BGMD) Is Tumbling on Thursday Apr 03 2014
    BG MEDICINE, INC. Files SEC form 10-K, Annual Report Mar 27 2014
    Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term... Mar 25 2014
    BG Medicine reports clinical utility of BGM Galectin-3 Test Mar 25 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial